Edarbi tablets (azilsartan medoxomil) for the treatment of high blood pressure (hypertension) in adults has been approved by the Food and Drug Administration (FDA), USA. The FDA says it approved Edarbi after examining data from clinical studies which clearly demonstrated Edarbi's superior efficacy compared to two already FDA-approved medications - Benicar (olmesartan) and Diovan (valsartan ...

The U.S. Food and Drug Administration approved Edarbi tablets (azilsartan medoxomil) to treat high blood pressure (hypertension) in adults. Data from clinical studies showed Edarbi to be more effective in lowering 24-hour blood pressure compared with two other FDA-approved hypertension drugs, Diovan (valsartan) and Benicar (olmesartan). "High blood pressure is often called the 'silent killer ...

In draft guidelines on the diagnosis and treatment of high blood pressure (hypertension) published this week, NICE has made a number of new recommendations that are set to significantly change the way high blood pressure is diagnosed and subsequently treated...

(Ivanhoe Newswire) -- About 74.5 million people in the United States ages 20 and older have high blood pressure (hypertension), according to the American Heart Association. What’s more, high blood pressure killed 56,561 people in the United States in 2006. It's a serious health risk for many Americans; however, difficult-to-control hypertension could be something of the past thanks to a novel ...

Increased intakes of anthocyanins – mainly from blueberries and strawberries – were associated with a reduction in the risk of high blood pressure ( hypertension ) of up to 12 percent, according to a collaboration between scientists from the University of East Anglia (UK), Harvard School of Public Health, and Harvard Medical School.